4SM intends to become the one stop shop for plasma based technologies ranging from non-invasive cosmetic & aesthetic systems and wound care products (phase one), to bespoke solutions for sterilisation in food & pharmaceutical (phase two). These revolve around our core technology IP and will be achieved through B2B, direct sales, research grants and licensing.


4SM is a growing company looking for equity investment to take our first product to market. This next funding round will complete late stage clinical trials, product positioning and marketing. Our current shareholders include the NHS, Harley Street clinicians, and a range of Angels.

Investment/Funding (dilutive and grant), Partner Organisations, Promotion

For more information contact
Dr Thomas Frame
+44 (0) 7921 500837